fundvisualizer.com

Driehaus Small Cap Growth InstitutionalDNSMX

Performance (before sales charge)

As of 08/31/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 07/31/2024
Stock
86.59%
Non-U.S. Stock
9.06%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
4.35%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 07/31/2024

Basic materials

3.42%

Consumer cyclical

10.19%

Financial services

6.34%

Real estate

0.00%

Consumer defensive

5.72%

Health care

21.67%

Utilities

0.00%

Communication services

1.16%

Energy

5.44%

Industrials

24.74%

Technology

16.33%

Top 10 holdings

As of 07/31/2024

Northern Institutional US Govt Sel
4.40%
Crinetics Pharmaceuticals Inc
2.60%
TransMedics Group Inc
2.56%
FTAI Aviation Ltd
1.98%
Axon Enterprise Inc
1.88%
Vaxcyte Inc Ordinary Shares
1.85%
Cameco Corp
1.71%
Modine Manufacturing Co
1.65%
Xenon Pharmaceuticals Inc
1.59%
Glaukos Corp
1.58%
Fund assets

$871.1 Million

Share class

Inst

Morningstar category

Small Growth

Expense ratio

0.73%

Investment objective

Small Company

Documents